EPO and Insulin resistance: A more likely hypothesis seems to be that ERFE may be part of a more complex mechanism related to EPO activity, which has demonstrated beneficial metabolic effects in numerous studies in both experimental models and humans, including reduced insulin resistance and improved lipid and adipocytokine profiles [30,31,32].